Home › NDC Lookup › RxCUI directory › RxCUI 847749

Lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution [Kaletra] — RxCUI 847749

Name: Lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution [Kaletra] (RxCUI 847749)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 847749 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI847749

Official nameLopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution [Kaletra]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asKaletra 80 MG / 20 MG per 1 ML Oral Solution; Kaletra 80 MG / 20 MG in 1 mL Oral Solution

FDA products mapped5

Package NDCs mapped5

Reported Medicaid activity (SDUD)51 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lopinavir and Ritonavir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Lopinavir and ritonavir won't cure HIV, but it's a key part of keeping the virus under control. It works by blocking a protein HIV needs to make copies of itself, which keeps the v...
What exactly does this medication do, and will it cure my HIV?
If you're taking the tablets — whether Kaletra or the generic — you can take them with or without food, which gives you flexibility. Just remember to swallow them whole; don't chew...
Does it matter when I take it, and do I need to take it with food?

📖 Read our full Lopinavir and Ritonavir guide →

🕸️ Concept Web — How Lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Sol... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution [Kaletra] RxCUI 847749 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 3

The active substance itself — no strength, form, or brand attached yet.
- Lopinavir 195088 IN
- Ritonavir 85762 IN
- Lopinavir / ritonavir 284640 MIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Kaletra 284756 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Lopinavir / ritonavir Oral Solution 374643 SCDF
- Lopinavir / ritonavir Oral Liquid Product 1163857 SCDG
- Lopinavir / ritonavir Oral Product 1163858 SCDG
- Lopinavir / ritonavir Oral Solution [Kaletra] 847748 SBDF
- Kaletra Oral Liquid Product 1168552 SBDG
- Kaletra Oral Product 1168546 SBDG
- Oral Solution 316968 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution 311369 SCD
- Lopinavir 80 MG/ML 331538 SCDC
- Ritonavir 20 MG/ML 332450 SCDC
- Lopinavir 80 MG/ML / ritonavir 20 MG/ML [Kaletra] 847747 SBDC

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution SCD · 311369
Lopinavir 80 MG/ML SCDC · 331538
Ritonavir 20 MG/ML SCDC · 332450
Lopinavir / ritonavir Oral Solution SCDF · 374643
Lopinavir / ritonavir Oral Liquid Product SCDG · 1163857
Lopinavir / ritonavir Oral Product SCDG · 1163858

Brand-Name Concepts

Lopinavir 80 MG/ML / ritonavir 20 MG/ML [Kaletra] SBDC · 847747
Lopinavir / ritonavir Oral Solution [Kaletra] SBDF · 847748
Kaletra Oral Liquid Product SBDG · 1168552
Kaletra Oral Product SBDG · 1168546
Kaletra BN · 284756

📦 FDA Products & Package NDCs

5 products · 5 package NDCs

5 package NDCs map to RxCUI 847749 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00074-0522-60	60 TABLET, FILM COATED in 1 BOTTLE (0074-0522-60)	Kaletra	AbbVie Inc.	2010-06-18
00074-3008-60	60 TABLET, FILM COATED in 1 BOTTLE (0074-3008-60)	Kaletra	AbbVie Inc.	2024-06-14
00074-3956-46	1 BOTTLE in 1 CARTON (0074-3956-46) / 160 mL in 1 BOTTLE	Kaletra	AbbVie Inc.	2010-06-18
00074-4014-12	120 TABLET, FILM COATED in 1 BOTTLE (0074-4014-12)	Kaletra	AbbVie Inc.	2024-02-15
00074-6799-22	120 TABLET, FILM COATED in 1 BOTTLE (0074-6799-22)	Kaletra	AbbVie Inc.	2010-06-18

Observed labelers: AbbVie Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.